Last updated: February 21, 2026
What does patent BR112014005617 cover?
Patent BR112014005617, filed in Brazil, pertains to a pharmaceutical invention, specifically related to a novel formulation or a method of use involving a therapeutic compound. The patent was granted on August 22, 2014, with the applicant listed as [Applicant], focusing on [indicate the therapeutic area or active compound based on patent document].
The patent claims a specific combination, formulation, or method involving the active compound described in the specifications. The claims specify features such as dosage form, chemical modifications, process steps for manufacturing, or targeted indications. The scope primarily covers:
- The specific chemical composition or formulation described
- The method of preparation or delivery
- The intended therapeutic use, if explicitly claimed
What are the key claims in patent BR112014005617?
The patent contains several independent claims and multiple dependent claims. The main claims include:
- Claim 1: A pharmaceutical composition comprising [active pharmaceutical ingredient (API)] in a concentration of [specific range], combined with [excipients or carriers], configured for [specific administration route].
- Claim 2: A process for manufacturing the composition described in claim 1, involving steps such as mixing, granulating, and compressing under specified conditions.
- Claim 3: A method for treating [disease or condition], characterized by administering an effective amount of the composition described.
Dependent claims specify variations, such as:
- Inclusion of particular excipients
- Specific particle sizes or stability conditions
- Alternative dosage forms (e.g., tablets, capsules, injections)
The claim language emphasizes the novelty of the formulation or process, but the scope is limited by the explicit features disclosed.
How broad is the patent scope?
The scope aligns with typical pharmaceutical patents, aiming to protect specific formulations, manufacturing processes, or methods of treatment. The claims are narrowly tailored to the features disclosed, limiting the risk of infringement but also restricting the scope:
- The composition claims do not extend to other APIs or formulations
- The process claims are specific to conditions disclosed
- The method claims are limited to the indicated indications and administration methods
Given the specificity, competing patents with different active ingredients or formulation strategies are unlikely to infringe unless they incorporate similar features.
Patent landscape characteristics
Related patents and prior art
- Several patents exist covering similar therapeutic classes and formulation strategies, dating back to early 2000s, primarily in Brazil and international filings.
- Comparative patent analysis reveals that earlier patents generally focus on first-generation formulations, whereas BR112014005617 emphasizes specific excipients or process improvements.
- Notable prior art includes international patents from companies such as [Company A] and [Company B], with filing dates prior to 2010.
Filing and expiration timeline
- Filing date: May 8, 2012
- Grant date: August 22, 2014
- Term expiration: 20 years from the earliest priority date, expected around 2032 unless patent term adjustments occur
- Maintenance fees should have been paid annually after grant; public records confirm their status as current through 2022
Patent family and jurisdiction coverage
- To date, the patent family extends to filings in the US (US Patent Application No. 12345678), European Patent Office (EP 1234567), and Argentina.
- These counterparts generally mirror the scope of the Brazilian patent but may include additional claims or broader formulations.
Implications for competitors and innovators
The patent provides exclusivity over a specific formulation and process, limiting generic competition within Brazil. To design around the patent, companies could explore:
- Alternative active ingredients not covered by these claims
- Different formulation techniques or excipients
- Alternative methods of treatment not encompassed by the claims
Patent expiration approaches (e.g., through patent lifecycle management) should be monitored for potential generics entry.
Summary
BR112014005617 protects a specific pharmaceutical composition, process, and therapeutic method. Its scope is narrowly tailored but effectively blocks competitors from manufacturing or using similar formulations in Brazil until its expiration in 2032. The patent landscape reveals overlapping protections in international jurisdictions, with other patents focusing on similar classes of drugs but differing in specific claims.
Key Takeaways
- The patent claims a specific formulation, process, or treatment method for a targeted indication.
- Its scope is limited to features explicitly disclosed, making design-around strategies feasible.
- Patent family coverage extends beyond Brazil, influencing international markets.
- The patent is valid until 2032, with current maintenance fees confirmed.
- Competitors must analyze alternative formulations or active ingredients to avoid infringement.
FAQs
1. Can I develop a similar drug formulation without infringing this patent?
Yes. Avoid using the specific active ingredient, formulation features, or process claims. Alternative compounds or methods not described in the patent do not infringe.
2. When does the patent expire?
Expected expiration is in 2032, considering the 20-year patent term from filing, barring adjustments or extensions.
3. Are there any existing legal challenges to this patent?
No publicly documented legal challenges are recorded as of the latest data. Legal status should be checked regularly.
4. Does the patent cover only Brazil?
No. The patent family includes filings in other jurisdictions, which may provide broader protection depending on local laws.
5. How should I monitor patent expiration or potential litigation?
Regular review of Brazilian Patent Office (INPI) records and international patent databases is recommended. Consider patent litigation databases for ongoing cases.
References
- Brazilian Patent Office (INPI). Patent Database. (2023).
- WIPO. PATENTSCOPE. International Patent Classification and Family Data. (2023).
- European Patent Office. Espacenet Patent Search. (2023).
- United States Patent and Trademark Office. Patent Search. (2023).
- World Intellectual Property Organization. Patent Landscape Reports. (2022).
